{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:48:49Z","timestamp":1789742929015,"version":"4.0.1"},"reference-count":46,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1686,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1747-0285.2010.01064.x","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T15:33:29Z","timestamp":1291390409000},"page":"173-181","source":"Crossref","is-referenced-by-count":51,"title":["Docking, Synthesis, and in vitro Evaluation of Antimitotic Estrone Analogs"],"prefix":"10.1111","volume":"77","author":[{"given":"Andre","family":"Stander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fourie","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,19]]},"reference":[{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drup.2007.06.003","article-title":"Mitotic drug targets and the development of novel anti-mitotic anticancer drugs","volume":"10","author":"Schmidt","year":"2007","journal-title":"Drug Resist Updat"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1025513106330","article-title":"Microtubules, microtubule-interfering agents and apoptosis","volume":"8","author":"Mollinedo","year":"2003","journal-title":"Apoptosis"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1568011053352569","article-title":"Targeting microtubules for cancer chemotherapy","volume":"5","author":"Zhou","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1158\/1535-7163.MCT-06-0113","article-title":"2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules","volume":"5","author":"Kamath","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1039\/b306797c","article-title":"Combretastatins: from natural products to drug discovery","volume":"20","author":"Cirla","year":"2003","journal-title":"Nat Prod Rep"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.drup.2003.10.001","article-title":"Mechanism of action of 2-methoxyestradiol: new developments","volume":"6","author":"Mooberry","year":"2003","journal-title":"Drug Resist Updat"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1073\/pnas.91.9.3964","article-title":"2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/0008-5472.CAN-05-2391","article-title":"The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells","volume":"66","author":"Newman","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0960-0760(95)00214-6","article-title":"Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application","volume":"55","author":"Elger","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1021\/jm060705x","article-title":"2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity","volume":"49","author":"Leese","year":"2006","journal-title":"J Med Chem"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0006-291X(03)00865-9","article-title":"Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates","volume":"305","author":"Ho","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1016\/j.bmc.2007.04.020","article-title":"Carbonic anhydrases as targets for medicinal chemistry","volume":"15","author":"Supuran","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1357-4310(99)01615-9","article-title":"Causes and consequences of tumour acidity and implications for treatment","volume":"6","author":"Stubbs","year":"2000","journal-title":"Mol Med Today"},{"issue":"Suppl. 4","key":"10.1111\/j.1747-0285.2010.01064.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1464-410X.2008.07642.x","article-title":"Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia","volume":"101","author":"Pastorekova","year":"2008","journal-title":"BJU Int"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1006\/jmbi.1998.2401","article-title":"Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation","volume":"285","author":"Word","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:JCAM.0000035186.90683.f2","article-title":"VEGA--an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming","volume":"18","author":"Pedretti","year":"2004","journal-title":"J Comput Aided Mol Des"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem Rev"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/ci600469w","article-title":"Analysis of human carbonic anhydrase II: docking reliability and receptor-based 3D-QSAR study","volume":"47","author":"Tuccinardi","year":"2007","journal-title":"J Chem Inf Model"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.sbi.2008.01.004","article-title":"Flexible ligand docking to multiple receptor conformations: a practical alternative","volume":"18","author":"Totrov","year":"2008","journal-title":"Curr Opin Struct Biol"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/bi802035f","article-title":"Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties","volume":"48","author":"Genis","year":"2009","journal-title":"Biochemistry"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J Mol Graph Model"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"13166","DOI":"10.1021\/jp060163v","article-title":"New-generation amber united-atom force field","volume":"110","author":"Yang","year":"2006","journal-title":"J Phys Chem B"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/jm00012a003","article-title":"Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site","volume":"38","author":"Cushman","year":"1995","journal-title":"J Med Chem"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.bmcl.2004.04.027","article-title":"2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents","volume":"14","author":"Leese","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1021\/jm049647a","article-title":"Effects of altering the electronics of 2-methoxyestradiol on cell proliferation, on cytotoxicity in human cancer cell cultures, and on tubulin polymerization","volume":"47","author":"Edsall","year":"2004","journal-title":"J Med Chem"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB31|cit31","first-page":"1538","article-title":"Novel 2-methoxyestradiol analogues with antitumor activity","volume":"63","author":"Tinley","year":"2003","journal-title":"Cancer Res"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB32|cit32","doi-asserted-by":"crossref","DOI":"10.1007\/s10637-009-9383-9","article-title":"A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer","author":"Zhou","year":"2010","journal-title":"Invest New Drugs"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/1535-7163.MCT-08-0107","article-title":"Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198","volume":"7","author":"LaVallee","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jsbmb.2005.01.022","article-title":"The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells","volume":"94","author":"Utsumi","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/cber.19580910633","article-title":"Hydrazinsulfons\u00e4ure-amide, I. \u00dcber das Hydrazodisulfamid","volume":"91","author":"Appel","year":"1958","journal-title":"Chem Berichte"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0003-2697(86)90314-3","article-title":"Determination of cell number in monolayer cultures","volume":"159","author":"Gillies","year":"1986","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0003-2697(89)90710-0","article-title":"Quantification of cells cultured on 96-well plates","volume":"182","author":"Kueng","year":"1989","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB38|cit38","first-page":"622","article-title":"The National Cancer Institute: cancer drug discovery and development program","volume":"19","author":"Grever","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0960-0760(97)00196-9","article-title":"The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity","volume":"64","author":"Purohit","year":"1998","journal-title":"The Journal of steroid biochemistry and molecular biology"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0003-9861(63)90548-4","article-title":"Estrogens. V. Studies on the relationship of estrogenic activity and molecular structure","volume":"101","author":"Patton","year":"1963","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1071\/RD01029","article-title":"Estrogen sulfamates: a new approach to oral estrogen therapy","volume":"13","author":"Elger","year":"2001","journal-title":"Reprod Fertil Dev"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00364838","article-title":"The crystal violet nuclei staining technique leads to anomalous results in monitoring mammalian cell cultures","volume":"21","author":"Berry","year":"1996","journal-title":"Cytotechnology"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0022-4731(89)90455-X","article-title":"The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells","volume":"32","author":"Seegers","year":"1989","journal-title":"Journal of steroid biochemistry"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cbf.1409","article-title":"In vitro effects of 2-methoxyestradiol on cell morphology and Cdc2 kinase activity in SNO oesophageal carcinoma cells","volume":"25","author":"Joubert","year":"2007","journal-title":"Cell Biochem Funct"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/cbf.1489","article-title":"In vitro effects of 2-methoxyestradiol on MCF-12A and MCF-7 cell growth, morphology and mitotic spindle formation","volume":"26","author":"Van Zijl","year":"2008","journal-title":"Cell Biochem Funct"},{"key":"10.1111\/j.1747-0285.2010.01064.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/07357900802653464","article-title":"Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells","volume":"27","author":"Li","year":"2009","journal-title":"Cancer Invest"}],"container-title":["Chemical Biology &amp; Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1747-0285.2010.01064.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T03:27:07Z","timestamp":1625628427000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1747-0285.2010.01064.x"}},"subtitle":["Docking, Synthesis, and in vitro Evaluation"],"short-title":[],"issued":{"date-parts":[[2011,1,19]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1747-0285.2010.01064.x","relation":{},"ISSN":["1747-0277"],"issn-type":[{"value":"1747-0277","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,19]]}}}